255 related articles for article (PubMed ID: 16318400)
1. Oxidative stress in insulin-resistant conditions: cardiovascular implications.
Stump CS; Clark SE; Sowers JR
Treat Endocrinol; 2005; 4(6):343-51. PubMed ID: 16318400
[TBL] [Abstract][Full Text] [Related]
2. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
Sowers JR; Frohlich ED
Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051
[TBL] [Abstract][Full Text] [Related]
3. Insights into the biology of diabetic vascular disease: what's new?
Sowers JR; Stump CS
Am J Hypertens; 2004 Nov; 17(11 Pt 2):2S-6S; quiz A2-4. PubMed ID: 15539107
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins.
Bagul PK; Banerjee SK
Curr Pharm Des; 2013; 19(32):5663-77. PubMed ID: 23448490
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in diabetes mellitus.
Hadi HA; Suwaidi JA
Vasc Health Risk Manag; 2007; 3(6):853-76. PubMed ID: 18200806
[TBL] [Abstract][Full Text] [Related]
6. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Coccheri S
Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes, cardiovascular risk, and the link to insulin resistance.
Stolar MW; Chilton RJ
Clin Ther; 2003; 25 Suppl B():B4-31. PubMed ID: 14553864
[TBL] [Abstract][Full Text] [Related]
8. Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab A
Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.
El-Atat F; McFarlane SI; Sowers JR
Curr Hypertens Rep; 2004 Jun; 6(3):215-23. PubMed ID: 15128475
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Yamagishi S; Takeuchi M
Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
[TBL] [Abstract][Full Text] [Related]
11. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
Hayashi T; Takai S; Yamashita C
Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
[TBL] [Abstract][Full Text] [Related]
12. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
Manrique C; Lastra G; Gardner M; Sowers JR
Med Clin North Am; 2009 May; 93(3):569-82. PubMed ID: 19427492
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes.
Patel TP; Rawal K; Bagchi AK; Akolkar G; Bernardes N; Dias DDS; Gupta S; Singal PK
Heart Fail Rev; 2016 Jan; 21(1):11-23. PubMed ID: 26542377
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.
Jia G; Sowers JR
Hypertension; 2021 Nov; 78(5):1197-1205. PubMed ID: 34601960
[TBL] [Abstract][Full Text] [Related]
15. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
Naidoo DP
Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree.
Di Filippo C; Verza M; Coppola L; Rossi F; D'Amico M; Marfella R
Curr Diabetes Rev; 2007 Nov; 3(4):268-73. PubMed ID: 18220686
[TBL] [Abstract][Full Text] [Related]
17. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, hypertension, and cardiovascular disease: an update.
Sowers JR; Epstein M; Frohlich ED
Hypertension; 2001 Apr; 37(4):1053-9. PubMed ID: 11304502
[TBL] [Abstract][Full Text] [Related]
19. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
Deedwania PC
Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619
[TBL] [Abstract][Full Text] [Related]
20. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.
Saad MI; Abdelkhalek TM; Saleh MM; Kamel MA; Youssef M; Tawfik SH; Dominguez H
Endocrine; 2015 Dec; 50(3):537-67. PubMed ID: 26271514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
